Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
neuromodulation
Press Release
Sep 30, 2021
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
This trial marks the first step taken by Actipulse Neuroscience to use a new method of neuromodulation to stop or slow Alzheimer's disease, an issue that fails to be solved by anything currently available on the market
Read More
Press Release
Jul 8, 2021
Actipulse Neuroscience Begins a Public Fundraising to Finance FDA Pivotal Trial of Proprietary Neuromodulation Medical Device
The company aims to advance fast and effective development of an at-home neuromodulation device for Major Depressive Disorder treatment.
Read More
Press Release
Jun 30, 2021
Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease
Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations
Read More
Press Release
Dec 18, 2019
Sooma Closes an Investment Round of Over 1.2 Million EUR
Read More
Press Release
Nov 19, 2019
EBT Secures USD $10M Series A
Company wins funding from world-class venture capital sources for its disruptive noninvasive electrical neuromodulation therapy aimed at treating overactive bladder (OAB)
Read More
Press Release
Nov 19, 2019
EBT Secures USD $10M Series A
Company wins funding from world-class venture capital sources for its disruptive, noninvasive electrical neuromodulation therapy, aimed at treating overactive bladder (OAB)
Read More
Press Release
Oct 16, 2019
Dr. Eric Grigsby Recognized for Visionary Leadership in Pain Management
CEO and Founder of Neurovations Honored as Patient Champion
Read More
Press Release
Jul 3, 2019
IDTechEx Forecasts Peripheral Nerve Stimulation Market to Grow at 35% CAGR, 2019-2029
Read More
Press Release
Jan 11, 2019
Sooma Medical Awarded US Patent for Advanced Stimulation Electrode
Read More
Press Release
May 14, 2018
Revolutionary Neuromodulation Technology Confirmed as Effective Treatment for Diabetic Neuropathy in Interim Study Results
Read More
Press Release
Apr 11, 2018
Xavant Technology Set to Disrupt Neuropathic Pain Treatment in the UK
Trial study at St. Thomas's Pain Management Centre shows dramatic effectiveness to treat chronic intractable pain
Read More
Press Release
Dec 26, 2016
Pain Relieving VibraCool® Debuts During Walt Disney World Marathon Weekend
Makers of Buzzy® Needle Pain Relief to attend runDisney Health and Fitness Expo for product demonstrations and sales
Read More
Press Release
Nov 23, 2016
MMJ Labs Innovates Pain Relief With VibraCool® Neuromodulation Device
Makers of Buzzy® Needle Pain relief today introduced a new noninvasive pain relief system for chronic and everyday pain sufferers.
Read More
Press Release
Dec 2, 2015
IQ4I Published a New Report on "Neuromodulation Devices Global Market - Forecast to 2021"
IQ4I estimated by IQ4I Research that the Neuromodulation devices global market is expected to reach $9.3 billion by 2021.
Read More
Press Release
Jul 29, 2015
Neuroscience Experts to Congregate in Barcelona, Spain on 3rd and 4th December 2015
Neuroscience R&D Technologies Conference to be held in Barcelona, Spain on 3 - 4 December 2015 will gather global neuroscience experts to discuss developments in brain imaging, animal models, neurogames, neuroinformatics and neuromodulation among others.
Read More
Press Release
Mar 24, 2014
Beckman Institute Initiates Study Using Soterix Medical HD-tDCS for Fluid Intelligence: $12.7million in Funding Through IARPA
Soterix Medical Inc. announces a multidisciplinary study based at the University of Illinois Beckman Institute to determine if High-Definition tDCS (HD-tDCS) in conjunction with other interventions improves adaptive reasoning and fluid intelligence.
Read More
Press Release
Aug 20, 2013
Soterix Medical Awarded Patent for Optimized High-Definition Transcranial Direct Current Stimulation
Soterix Medical, Inc. announces allowance of claims from the U.S. Patent Office for an application covering their system and method of non-invasive neuromodulation using the proprietary High-Definition transcranial Direct Current Stimulation platform
Read More
Press Release
Mar 19, 2012
Cerbomed GmbH Selects Clinicalprojects International GmbH To Run Its International Epilepsy Trial
Cerbomed GmbH, an innovative medical device company concentrated on the development of new technologies for neuromodulation, has selected the CRO clinicalprojects international GmbH (CPI) to drive its multi-center European epilepsy trial.
Read More
First
Prev
1
Next
Last